| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Antibody Analytics We provide drug developers with data of outstanding quality to give them confidence to expedite new healthcare solutions At Antibody Analytics we believe that scientists deserve the best data, and patients deserve the best drugs. Led by a group of talented and engaged scientists, we look at biological problems in an openminded way to deliver beautifully designed, developed and qualified bioassays. We have developed a comprehensive portfolio of assays and platforms that can be tailored to support even the most complex of drug pipelines. Whether designing and developing bespoke bioassays or offering routine analysis on our already established assay platforms, … Type: | 0 | 0 | 0 | 84 |
 | Onena Medicines AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases. Onena’s drugs neutralize a new class of secreted ancient growth factors, conserved across species, called Dual SMAD Inhibiting Proteins (DSIPs), that program cancer cells to grow and resist chemotherapy. Blocking DSIPs, as demonstrated in-vivo by Onena, simultaneously reactivates physiological TGF-β and BMP signaling and elicits cellular reprogramming, resulting in cancer cells accepting environmental cell death signals from BMPs and Activins. Onena has developed … Type: | 0 | 0 | 0 | 11 |
 |  ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 4 | 0 | 2 | 17 |
 | 4D Lifetec AG First Swiss Liquid Biopsy for the early detection of cancer based on a new innovative transformational biomarker About 4D Lifetec AG 4D Lifetec is a pioneer on a mission to revolutionize early cancer detection. Our easy and powerful blood tests can detect cancer at its earliest stages (I and II), offering you peace of mind and proactive well-being protection. Sophisticated artificial intelligence (AI) enhances our immunological high-throughput blood assays which in turn enables timely intervention and treatment. Molecular Diagnostics, Oncology, Genotoxicity, DNA Damage and Repair, Liquid Biopsy, Biomarker, Early cancer detection, Early cancer diagnosis, Cancer test, Lung Cancer, and Bronchoscopy Type: | 0 | 0 | 0 | 9 |
 | Tessellate BIO Redefining Synthetic Lethality beyond HRD Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion. drug discovery, precision oncology, and biotechnology Type: | 0 | 0 | 0 | 23 |
 | Volteras Enabling innovation in the electric vehicle ecosystem. Volteras is a high-growth startup specialising in electric vehicle software. Our mission is to organise and leverage data to accelerate the transition to a greener and smarter future. Come build a clean energy future with us. Type: | 2 | 0 | 2 | 12 |
 | Minervax ApS Developing a maternal vaccine for Group B Streptococcus MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates. Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns. Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery. Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, … Type: | 0 | 0 | 0 | 47 |
 | ADOR Diagnostics Molecular Diagnostics Innovations ADOR Diagnostics is an innovative IVD company that specializes in the development of cutting-edge syndromic multiplex molecular biology diagnostics technology. ADOR sets a new standard by revolutionizing the way laboratories worldwide diagnose infectious diseases with multiplex,sample-to-answer, fully automated systems that deliver accurate results rapidly. By using ADOR’s systems, laboratories can reduce costs and increase efficiency while doctors are able to treat patients with confidence, knowing they would prescribe the correct antibiotics and the right treatment. The NATlab system is a multiplex isothermal (RCA) based cutting-edge molecular biology platform with a bench-top modular analyzer and a disposable all-included … Type: | 0 | 0 | 0 | 20 |
 | Coriolis Pharma Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large … Type: | 0 | 0 | 0 | 181 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry Type: | 0 | 0 | 0 | 16 |
 | Cambrium Materials that matter. Cambrium's mission is to trigger the next wave of material innovation by harnessing biology’s molecular building blocks. We fundamentally believe that the ability to align economic and environmental incentives makes biology the most important manufacturing technology of the 21st century. Using our molecular design technology, we create novel material building blocks with previously inaccessible functionalities. Our molecules enable innovators to create products that are better for people, and the planet. We are a highly interdisciplinary team of scientists, engineers, designers and entrepreneurs, united by our vision to create materials that matter. Intrepid, vibrant, and purpose-driven we are … Type: | 8 | 3 | 7 | 29 |
 | Pixelgen Technologies Pioneering Spatial Proteomics for Single Cells Pixelgen Technologies AB was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs with a vision to bring a new spatial understanding to biology by developing tools to facilitate the mapping of cell surface proteins and their spatial inter-relationships. Life operates by the spatial orchestration of proteins and at Pixelgen we have developed Molecular Pixelation that analyses cell surface proteins in a completely new way. Using current technologies, there are limitations of light and taking images influencing how many proteins and how many samples that can be analysed concurrently. With molecular … Type: | 0 | 0 | 0 | 32 |
 | Orbem We combine MRI with advanced AI for fast, accurate, and contactless object classification and analytics. Unleashing AI-powered imaging for everything and everyone. Orbem combines rapid magnetic resonance imaging with advanced deep learning to shed light on the world's toughest challenges. We are developing fast, accurate, and accessible imaging solutions that reveal hidden sources of knowledge. In everything we do, we seek to make a difference – and are leveraging deep tech solutions to sustainably feed the world, accelerate the transition to a green economy, and transform disease detection. Based on years of scientific research at the interface of AI and … Type: | 2 | 1 | 1 | 104 |
 | LimmaTech Biologics AG Better technology for better health LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK. vaccines, research & development, and biotechnology Type: | 0 | 0 | 0 | 38 |
 | Memo Therapeutics AG Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis. Its DROPZYLLATM platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’s immune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. Combined with our microfluidic high throughput single cell-based functional screening system this leads to entirely new possibilities in immune repertoire analysis and antibody discovery. The business strategy of Memo Therapeutics is the discovery of … Type: | 2 | 1 | 2 | 35 |
 | Inovedis Rotator cuff repair: Increase efficiency, respect biology, optimize outcomes. Inovedis stands for innovation in medical technology. As insiders, we know the issues that affect doctors and patients in everyday clinical practice. Our new innovation, SINEFIXTM, came about because we wanted to improve the prevailing surgical method for refixation of the rotator cuff. And we have succeeded in doing that: For the first time, our PEEK implant creates a planar and stable connection between tendon and bone - and we assume that SINEFIXTM enables optimal healing. This saves time and money, for the doctors as well as their patients. In this … Type: | 0 | 0 | 0 | 7 |
 | HeartBeat.bio AG REINVENTING CARDIAC DRUG DISCOVERY HeartBeat.bio is building the worldwide first high-throughput human organoid cultivation, screening and AI-supported data analysis solution for developing first-in-class drugs to treat heart failure faster, less expensively and with a higher probability of success in clinical trials. The so-called Cardioid Drug Discovery Platform relies on self-assembling, highly reproducible cardiac organoids which recapitulate the human physiology and enable modeling of heart diseases in a way not achieved with other in-vitro systems. Currently, HeartBeat.bio is focused on drug-induced and different sub-types of genetic cardiomyopathies, followed by programs in diabetic cardiomyopathy, myocardial infarction, and cardiac remodeling. HeartBeat.bio was founded … Type: | 0 | 0 | 0 | 19 |
 | Agomab Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. Type: | 0 | 0 | 0 | 49 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 11 |
 | LIRIS [Automatic translation follows] Image Computer Science and Information Systems Laboratory | UMR5205 Computer Science Laboratory in Image and Information Systems | 6 | 5 | 1 | 256 |
 | Marigold Testing and developing implementations of Tezos Protocol Upgrade Proposal. @Tezos blockchain experts. Testing and developing implementations of Tezos Protocol Upgrade Proposal. Technical blog: https://marigold.dev/blog/ Twitter account: @Marigold_Dev Blockchain expertise, Mentorship, Web3 Development, dApps, Startups incubator, and Blockchain consultant Type: | 4 | 1 | 2 | 11 |
 | setec diadès [Automatic translation follows] The science of diagnosis, sustainability engineering, at the service of your structures. DIADES is the SETEC group company specializing in structural diagnostics and its main missions are: - diagnostic engineering, maintenance, repair and durability studies of engineering structures (bridges, walls, tunnels, dams, etc.), industrial civil engineering structures (factories, silos, chimneys, etc.). .) and maritime (quays, dykes, etc.), private or public buildings and historical monuments. - advice, training and assistance to public and private project owners in the management of their assets, maintenance, upkeep, pathology, diagnosis, repair and sustainability studies of their structures. - research with authorized organizations … Type: | 5 | 0 | 1 | 64 |
 | NATURALIA ENVIRONNEMENT [Automatic translation follows] The ecosystem serving the Living 📣 We are recruiting!!! 🍀🌳 Founded in 1998, Naturalia Environnement is an independent ecological consulting and engineering company. A major player in impact studies on biodiversity in accordance with current regulations, it also provides project management and project management assistance on the ecological aspect to public and private land development project leaders. With 20 years of experience, Naturalia-Environnement has around sixty people, the vast majority of whom are ecologists. With 3 regional departments and 9 agencies in mainland France, NATURALIA ENVIRONNEMENT undertakes several thousand days of field inventories each year for more … Type: | 11 | 3 | 2 | 81 |
 | COOP'ESKEMM [Automatic translation follows] Coop’Eskemm is a research and animation cooperative. Coop’Eskemm is a research and animation cooperative specializing in youth policies and the sociology of public action based in Rennes. By combining scientific research methods and methods from popular education, we support collective actions to support the processes of social, economic, cultural and political emancipation of young people. Type: | 11 | 1 | 1 | 6 |
 | Just - Evotec Biologics Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is … Type: | 4 | 2 | 2 | 511 |
 | Arkéa Flex [Automatic translation follows] Buildings that evolve with life Arkea Flex is a patented innovation developed by the Crédit Mutuel Arkea Group. This innovation implements architectural, technical and legal measures allowing user buyers to adapt their housing according to their needs at each important stage of life and investors according to market developments. This real, rapid and low-cost flexibility of development is part of a sustainable development approach. To find out more: https://www.youtube.com/watch?v=MpGd4HieJYA or on our website https://arkeaflex.fr/ Type: | 14 | 3 | 13 | 8 |
 | CEDEN® Rethinking Healthcare by personalizing Cannabis with Genomics and AI CEDEN® Is Rethinking Healthcare In 3 Effective Ways: Born from a vision of DEMOCRATIZING access to clean and affordable medicine, we have designed CEDEN® GROW to allow everyone to produce medical herbs right in the comfort of their home. CEDEN® PHARMA is using artificial intelligence to DISCOVER and DEVELOP cannabis based medicine to support humanity with natural cancer, pain or sleep remedy. CEDEN® COMMERCE is reinventing retail and DISTRIBUTION using artificial intelligence and data-science to personalize cannabis. Type: | 1 | 1 | 0 | 3 |
 | Mairie de Ramonville Saint-Agne [Automatic translation follows] Welcome to the LinkedIn page of Ramonville Saint-Agne town hall. ☀️ Located on the outskirts of Toulouse, within the urban community of Sicoval (south-east of the urban area), Ramonville Saint-Agne is today the 9th most populated municipality in Haute-Garonne, with nearly 15,000 inhabitants. Its demographic growth, one of the largest in the urban area, is the mark of confirmed attractiveness. 🌳 Crossed by the Canal du Midi, a UNESCO world heritage site, it enjoys an advantageous natural environment. In addition to its two river reception structures, the Port Sud marina and the technical port of call, the … Type: | 3 | 1 | 2 | 66 |
 | CORBEN [Automatic translation follows] Innovate to Heal Corben, based in Normandy, is a recognized player in the supply of medical and First Aid equipment. Specializing in immobilization and transfer, Corben also offers numerous products related to emergencies (resuscitation, suction, defibrillation, diagnosis, etc.), to specialist medicine (ECG, audiometry, spirometry – autonomous or interfaced) or even medical furniture. First Aid, Transport / Transfer, Advanced Medical Stations, Resuscitation, Medical Baggage, Vacuum Immobilization, Electronic Diagnostics, Standard Diagnostics, Immobilization, Respirators, Medical, Hospitals, Damage Control, and Army Type: | 3 | 2 | 0 | 15 |
 | Harvard University Harvard University is devoted to excellence in teaching, learning, and research, and to developing leaders in many disciplines who make a difference globally. Founded in 1636, Harvard is the oldest institution of higher learning in the United States. The official flagship Harvard social media channels are maintained by Harvard Public Affairs and Communications and aim to provide access to the people, places, events, news and research at our Institution. We ask that all visitors to Harvard’s digital spaces be civil to one another and to the site editors. Personal attacks, profanity, commercial solicitations, spam, misinformation or other inappropriate contributions are … Type: | 1 | 0 | 0 | 24,143 |
 | CNRS Centre-Est The CNRS Centre-Est, which oversees 70 structures, is one of the main public players in research in the region. With 70 operational structures and more than 1,225 employees, the CNRS in the Centre-East region is one of the main public research players in the region, alongside universities, higher education establishments and other national research organizations, with more than 3,500 publications per year. Recherche scientifique, Biologie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physiques, Sciences de l'information, Humain et société, Nucléaire et particules, Terre et Univers, and Sciences Type: | 19 | 3 | 10 | 9 |
 | Jacques Delors Centre Thinking Europe. Europa denken. Penser l’Europe. At the Jacques Delors Centre, academic research goes hand in hand with the development of concrete ideas for future-oriented EU policies. In our think tank work, our analyses provide an independent, non-partisan view of European policy processes and decisions. We develop concrete proposals for a better Europe. Through a variety of different formats and channels, we share our findings and ideas with decision-makers and the interested public and put political developments into perspective in real time. In our research work, we systematically close knowledge gaps on European integration. In close exchange with scholars from … Type: | 3 | 1 | 0 | 23 |
 |  CERU, le labo d'idées universitaire [Automatic translation follows] Skills at the service of convictions Founded in 2008, the University Study and Research Center is an independent laboratory of ideas which draws on the expertise of academics to shed light on current events and propose concrete solutions to political, geopolitical, societal and scientific challenges. and technologies that present themselves before us. The CERU brings together and brings together academics from different disciplinary fields, but sharing common values (promotion of excellence, sense of transmission and authority, defense of freedom, primacy of the person, rejection of communitarianism ,...) and the same respect for what scientific honesty should be. … Type: | 1 | 0 | 0 | 1 |
 | IPREM Institute of Analytical Sciences and Physico-Chemistry for Environment and Materials The IPREM is a Joint Research Unit of the CNRS / the University of Pau and Pays de l'Adour and, the IMT Mines Alès as a secondary supervisory body. Our mission is to develop knowledge in physical chemistry, analytical chemistry and microbiology for the environment and materials. Our know-how in the development of analytical strategies, modelling and elaboration is complemented by the fine study of structures and characterisation at different scales. Our work is mainly focused on the structure of living organisms, environmental management, bioinspiration and the valorisation of bioresources, … Type: | 11 | 4 | 7 | 54 |
 | HQI France [Automatic translation follows] Develop the use of hybrid #quantum computing in France! #France2030 HQI: a hybrid quantum HPC computing platform and a research program In January 2022, one year after the announcement by the President of the Republic of the National Quantum Plan, Neil Abroug, the coordinator of the national strategy launched HQI: France Hybrid HPC Quantum Initiative. HQI is an integrated initiative. It combines a hybrid computing platform coupling several quantum technologies to the Joliot Curie supercomputer from GENCI at the TGCC (CEA), and a research program – academic and industrial, and dissemination of uses. This quantum/HPC hybridization is … Type: | 27 | 7 | 16 | N/A |
 | CoWork'HIT [Automatic translation follows] Accelerator of innovative projects serving disability CoWork’HIT is a center of innovation, expertise and resources. Its main mission is to support companies, health and medico-social establishments, associations and other players in innovation and disability. It thus participates in the development of a sector that is still poorly structured in France. Innovation, Disability, Occupational Therapy, Start-Up, Research, Engineering, Projects, Accessibility, Development, Usage Tests, Regulations, Inclusion, Communication Aid, Home Automation, Digital Assistants, Digital Manufacturing, 3D Printing, Training, and RDI Type: | 20 | 4 | 17 | 14 |
 | Normandie Valorisation [Automatic translation follows] Passion for innovation Our job: make it your future Component of Normandie University, Normandie Valorisation aims to standardize and cohere the activities of the valorization structures, identify and detect the potential for transfer in the different research structures, organize the valorization process by implementing new tools and services , expertise, to support laboratory projects, boost the maturation of research projects in order to facilitate their transfer to the socio-economic world, improve the efficiency of transfer activities. Type: | 20 | 0 | 5 | 12 |
 | Medizone [Automatic translation follows] Partnership for health Medizone is a company that has a range of over 5,000 medical products. The concept underlying our entire activity is based on trust and sustainability. The systems and technologies integrated in the medical equipment that Medizone proposes can facilitate a series of medical procedures and analyzes as complete and complex as possible. With over 16 years of experience on the market, Medizone has achieved its goal of offering innovative and high-performance products that meet the highest standards. Our team constantly ensures that the treatment rooms and medical offices where our products end up enjoy … Type: | 1 | 1 | 0 | 54 |
 | CanCell [Automatic translation follows] Precision Oncology Solutions CanCell Personalized Cancer Treatment Solutions helps you reach the most appropriate treatment option with comprehensive genetic analysis services and more. | 1 | 1 | 0 | 5 |
 | Stiftung Hamburger Gedenkstätten und Lernorte zur Erinnerung an die Opfer der NS-Verbrechen [Automatic translation follows] The foundation maintains, expands and conveys knowledge about the National Socialist era through its memorial sites. The foundation commemorates the National Socialist crimes, researches and conveys their history and consequences, and preserves the memory of those persecuted by the Nazi regime. The foundation is the sponsor of memorial sites and learning centers in Hamburg. The focus is on the Neuengamme concentration camp memorial as an international place of remembrance. It also includes the Bullenhuser Damm memorial, the Fuhlsbüttel concentration camp and prison and Plattenhaus Poppenbüttel memorial sites, as well as the Stadthaus historical site and the future … Type: | 1 | 1 | 0 | 6 |
 | Technische Hochschule Lübeck "Wir machen Karrieren!" TH Lübeck is an innovation and transfer-oriented university of applied sciences, which is characterized by a high degree of practical focus in teaching and a high degree of application orientated research. With about 5,000 students in four departments and over 30 study programs, it is the largest university in the Hanseatic City of Lübeck. As an expert in natural and engineering sciences, economics, computer science, architecture and design, it shapes the region in economic and cultural terms. In accordance with its university type, it is regionally rooted and at the same time connected worldwide through its international … Type: | 5 | 1 | 3 | 400 |
 | Institut français de recherche sur le Japon à la Maison franco-japonaise [Automatic translation follows] Joint unit of French research institutes abroad (Umifre 19, MEAE-CNRS) The Franco-Japanese House of Tokyo is a Franco-Japanese cooperation system. It is made up of a Foundation under Japanese law: the Fondation Maison franco-japonaise, which hosts the French Institute for Research on Japan (UMIFRE 19) and a large library of literature and human and social sciences (SHS) in language French (50,000 volumes). This cooperation saw the light of day thanks to the patient will of a Franco-Japanese society formed at the end of the 19th century. She had the project of offering a place where a team … Type: | 1 | 1 | 0 | 5 |
 | Institut français du Proche-Orient (Ifpo) [Automatic translation follows] Human and social sciences research center in Lebanon, Syria, Jordan, Iraq and the Palestinian Territories Ifpo is a research center in the human and social sciences (SHS) of the network of French Institutes for Research Abroad (Ifre); it is placed under the dual supervision of the National Center for Scientific Research (CNRS) and the Ministry of Europe and Foreign Affairs (MEAE). Present in Iraq, Jordan, Lebanon, the Palestinian Territories and Syria (sites closed to the public), Ifpo covers all SHS relating to the region and its cultures from prehistory to the present day. archaeology, human and social … Type: | 3 | 1 | 2 | 118 |
 | Instituto Francés de Estudios Andinos [Automatic translation follows] 74 years of research in Social Sciences, Humanities and Archeology in the Andean countries The IFEA is both a research unit and a support platform for French and European research in collaboration with the Andean countries. It produces fundamental knowledge essentially in Social and Human Sciences and Archaeology. The in-depth analysis of social, economic, political and cultural processes allows it to fuel public debate thanks to its missions to disseminate knowledge that passes through different media (scientific editions, colloquiums and conferences, making available a library of investigation). It also serves as a support point for the training … Type: | 4 | 1 | 2 | 21 |
 | Maison Française d'Oxford The MFO is associated with the University of Oxford to support the special link btw the French & British academic worlds The Maison Française d’Oxford (MFO) was founded at the end of the Second World War on the joint initiative of the Universities of Paris and Oxford. With the support of the Chancery of the Universities of Paris, it maintains close links with French universities and the other French institutes of higher education. Associated with the University of Oxford, it is a hub of Franco-British academic collaborations. As a member of the network of research institutes established abroad by the … Type: | 3 | 2 | 2 | 16 |
 | Centre Marc Bloch Centre Marc Bloch is a company based out of 191 Friedrichstraße, Berlin, Berlin, Germany. | 2 | 1 | 1 | 64 |
 | VISAAL [Automatic translation follows] Patented, self-contained & connected Visaal, patented autonomous urinary device & connected. In a world where digital is experiencing significant growth, VISAAL strives to offer a connected product combining comfort, autonomy and hygiene for its customers. Founded in 2017, VISAAL is a product from the company Kahines Concept whose goal is to help medically treated people better cope with their loss of permanent or partial mobility thanks to technology. The objective of the start-up is based on three principles: Support, Improve, Help. Indeed, VISAAL now offers you a connected portable urinary device offering impeccable hygiene conditions as well … Type: | 1 | 1 | 0 | 5 |
 | PROTEOR Human First PROTEOR is the leader of P&O fitting in France and its expertise is recognized all over the world. PROTEOR develops two activities : - Custom-made orthopedic fitting of Patients thanks to a network of fitting centers set up near hospitals, clinics and rehabilitation centers to ensure geographic proximity with the patients. - Design, manufacture and sales of components for prosthesis, limb orthosis and spinal orthosis for the Professionals of the orthopedic field. orthopédie externe, prothèse, orthèse, corset, handicap, vieillesse, innovation, dispositif médical, bien-être, R&D, autonomie, and scoliose Type: | 3 | 2 | 1 | 406 |
 | Département de recherche Droit & transformations sociales (DETS) [Automatic translation follows] DETS is a research structure that aims to structure and lead research in law and political science. The Department of Law and Social Transformations at the University of Bordeaux integrates all dimensions of research in law, legal history and political science (public, private, internal, international and European, comparative). In doing so, it can mobilize the entire disciplinary field and capture, in an unprecedented way, all the normative manifestations of social transformations and promote legal and political methods as such. The department's mission is to develop research in law and political science. These functions involve in particular the … Type: | 5 | 1 | 3 | N/A |
 | Caylar SAS Magnetic systems Magnetic systems manufacturer - High-precision NMR magnetic field measurement - High-precision, high-stability current sources - Electromagnets Electromagnets, NMR Gaussmeter, and Power supply | 1 | 1 | 1 | 15 |
 | Ministerul Cercetării, Inovării și Digitalizării [Automatic translation follows] The Ministry of Research, Innovation and Digitization is a specialized body of the central public administration. The Ministry of Research, Innovation and Digitization has a synthesis and coordination role in the fields of scientific research, experimental and technological development, innovation, communications and digitalization. The Ministry of Research, Innovation and Digitization is the state authority in the fields of research, experimental and technological development, innovation, communications and digitalization, cyber security, postal services, radio communications. At the same time, the Ministry of Research, Innovation and Digitization is the state authority in the fields of information technology, information society and … Type: | 1 | 1 | 0 | 90 |
 | EUCPN (European Crime Prevention Network) No matter the subject, the EUCPN is your first point of contact regarding crime prevention. The European Crime Prevention Network aims to connect the local, national and European level & to promote crime prevention knowledge and practices among the EU Member States. crime prevention, research, policy, Europe, European Union, campaigns, europeanunion, and crime Type: | 1 | 0 | 0 | 6 |
 | LE LORRAIN - HAMPIAUX SAS La maîtrise de la flamme - Mastering the Flame Founded in 1946, LE LORRAIN applies its technical expertise and technology to developing a complete range of Flame welding equipment for iron and steel and metallurgy industries, as well as boiler-makers, craftsmen and refrigeration technicians. The company covers the whole production line and quality control: from turning of the parts at the assembly and from the performing unit tests on Le Lorrain products, to shipment. Type: | 2 | 1 | 2 | 33 |
 | World Inequality Lab The World Inequality Lab works to produce and disseminate research on the various dimensions of inequality, both within and between countries. Its core mission is to maintain and expand the World Inequality Database, the most extensive public database on global inequality dynamics. The World Inequality Lab also produces inequality reports and working papers addressing thematic and methodological issues. The 2022 edition presents the most up-to-date synthesis of international research efforts to track global inequalities: https://wir2022.wid.world/ The WIL is composed of about thirty researchers and staff. It is hosted at the Paris School of Economics and the University of Berkeley, California. … Type: | 1 | 0 | 0 | 25 |
 | PMG Technologies Notre mission : Préserver votre vie sur la route For the past 20 years, the Canadian Ministry of Transport, Transport Canada, has relied on PMG Technologies to manage the Motor Vehicle Test Center (MVTC). The MVTC, established by Transport Canada for compliance and research testing of motor vehicles is the only test facility of its kind in Canada and the most state of the art facility in North America. Certification, Training & Consulting, Conformity Testing, Homologation & Regulations, Crash Testing, Tracks Testing, Environmental Chamber Testing, Sled Testing, Structural Testing, Ride and Drive Events, and Research Type: | 1 | 1 | 0 | 57 |
 | Science politique Université de Montréal [Automatic translation follows] Stay in touch with your Political Science community Université de Montréal Network of graduates in political science, international studies, economics and politics, communication and politics and philosophy and politics from the University of Montreal. Type: | 1 | 1 | 0 | 10 |
 | EnsadLab Art & Design Research Laboratory at École des Arts Décoratifs, Paris Art & Design Research Laboratory at École des Arts Décoratifs, Paris. EnsadLab, the École des Arts Décoratifs research laboratory, was created in 2007. The laboratory centres on three areas – materials, interactions and environment – with the goal of using a research-led approach to train a new generation of artists and designers and offer them a practice-based doctorate. It is home to some thirty doctoral and pre-doctoral students as well as around thirty research lecturers who are artists and designers, divided into five research groups. EnsadLab is the first … Type: | 6 | 1 | 5 | 20 |
 | Nanobots Therapeutics Therapeutics In-Motion A Biomedical Company Improving Drug Accumulation In Cancer Cells Type: | 1 | 0 | 1 | 5 |
 | 3D Bio-Tissues Applying biology to the creation of 3D structured tissues such as cultivated meat, lab-grown leather, skin and cornea! We are an ambitious start up, aiming to bring functional tissue engineered products to the market. Our unique technology creates tissues with the same nanoscale structural features found in actual living tissue. This allows our tissues to be truly functional and not a random mass of cells and materials. We are taking the lead on creating 100% lab grown meat, that means scaffold free! We are also wholly owned by BSF enterprise which is listed company, in fact we are the only … Type: | 1 | 1 | 0 | 14 |
 | Pencil Biosciences Limited Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing Type: | 0 | 0 | 0 | 15 |
 | Ecohelix Changing the world with wood-based biopolymers Ecohelix is a Stockholm based biotech company currently scaling up a proprietary biopolymer processing technology towards production. At Ecohelix, we are confident that a large quantity of chemicals and materials can in be manufactured sustainably from forestry based raw materials. Our partnering mills has the raw material and we have the technology to make this vision a reality. We can help make packaging, cosmetics and house care more sustainable with our Woodmer products. Process technology, Biotechnology, Polymer production, and Renewables Type: | 2 | 0 | 2 | 16 |
 | Machine Discovery Oxford University spin-out that accelerates simulation workflow. We're hiring! We jump-start innovation — we speed up your simulation workflow by orders of magnitude. We’re an Oxford University spin-out, founded by world-class physicists and machine learning engineers. The benefits of our technology have been covered by Science Mag and Nature Physics, and we’re already delivering a substantial competitive advantage to our early customers. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity. You describe your simulation, we provide everything else — from automatic optimization of parameters to advanced statistical … Type: | 2 | 1 | 1 | 18 |
 | Akari Therapeutics, Plc Developing novel advanced therapies to address unmet needs of patients with autoimmune & inflammatory diseases. Akari Therapeutics, Plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari’s pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). Akari has been granted Orphan Drug, Fast Track and Rare Pediatric Disease designations from the FDA for nomacopan for the treatment of pediatric HSCT-TMA and orphan drug designation … Type: | 0 | 0 | 0 | 16 |
 | Cellply Unravelling immune system function, one cell at a time Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented … Type: | 0 | 0 | 0 | 35 |
 | Acesion Pharma Danish biotech developing novel treatments for Atrial Fibrillation Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF. Type: | 0 | 0 | 0 | 19 |
 | Transimmune AG Restoring immune surveillance through natural immunity - a revolution in dendritic cell therapy. Transimmune AG is leading a revolution in dendritic cell therapy having uncovered how dendritic cells are made physiologically in vivo. Type: | 0 | 0 | 0 | 3 |
 | Sitryx Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therapies Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at … Type: | 3 | 2 | 3 | 52 |
 | ParTec AG ParTec is a pioneer in the field of Modular Supercomputing and Quantum Computing. ParTec turns international projects in development and building Supercomputers into reality and is embedding Quantum Computing into various existing and soon-to-be systems. At ParTec AG, we design, build, and support purpose-built heterogeneous supercomputer solutions for science, using our modular high performance computing approach. Our team works in a fast growing technology company and cooperates closely with leading technology companies in this field for building some of the largest and most complex supercomputers in Europe. We integrate a broad range of products and compute technologies of different origin … Type: | 2 | 1 | 2 | 66 |
 | Avingtrans Pinpoint / Invest / Exit Avingtrans plc has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”. Significant shareholder value is delivered through a clear strategy, a strong balance sheet and an agile and experienced management team. M&A, Engineering, Manufacturing, Energy, Medical, Turnaround, Nuclear, Oil & Gas, Power, Industrial, Integration, Consolidation, Pumps, Motors, Steam Turbines, Pressure Vessels, and Containers | 0 | 0 | 0 | 9 |
 | Laverock Therapeutics Next generation programmable cell therapies Next generation programmable cell therapies Type: | 1 | 0 | 1 | 32 |
 | AbolerIS Pharma The Immune system under control Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases. Type: | 5 | 2 | 0 | 15 |
 | Nonna Lab [Automatic translation follows] French Foodceutical Laboratory. 3,000 partner pharmacies. At Nonna Lab, innovation rhymes with sensation Because we believe that health is a treasure, but we reject the idea that maintaining good health should be an austere experience. We are convinced that pleasure increases effectiveness tenfold. This is why we innovate every day in terms of substance and form to offer innovative solutions, revealing a unique sensory experience. At NONNA LAB, we are always seeking excellence to offer formulas highly concentrated in active nutrients and phytonutrients, which we design with precision, encapsulated in never-before-seen food matrices. Uncompromising on quality, we … Type: | 1 | 0 | 1 | 44 |
 | CHEPLAPHARM A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty … Type: | 0 | 0 | 0 | 374 |
 | Pathios Therapeutics Pioneering a novel macrophage conditioning approach to deliver breakthrough cancer therapies Pathios Therapeutics is an early-stage drug discovery company that was established in 2017 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of tumour-associated macrophages (TAMs). We are currently engaged in a fully-enabled drug discovery program to identify novel small-molecule modulators of GPR65 with expected utility across a broad spectrum of cancers. We are also more broadly interested in the potential to target GPR65 for benefit in a range of other serious … Type: | 2 | 0 | 0 | 19 |
 | VODORASLO® Bulgarian startup company creating #oceaninabox. Algaia’s project VODORASLO is developing a domestic photobioreactor device for air purification using algae as the main resource. The product is an indoor air solution for homes, schools, and offices where it can purify gases like CO2, NOX, SO2, and bigger pollutants such as PM2.5, PM10, and VOCs. It is working based on photosynthesis where algae are “eating” the gases to produce oxygen and biomass. The biomass can be used as a natural fertilizer for plants, biodegradable packaging, food supply, pigment or in cosmetics. VODORASLO already developed its first device in 2021, created one hundred … Type: | 1 | 0 | 1 | 3 |
 | Notify Therapeutics Novel treatment paradigm for infertile women. Through targeting of the early and hormone-independent phase of egg maturation, we aim at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy. Type: | 0 | 0 | 0 | 8 |
 | Opterion Health AG Improving Quality of Life of Peritoneal Dialysis Patients Opterion Health is focused to bring innovation to dialysis and foster peritoneal dialysis (PD). The company aims to improve the quality of life for patients as well as their loved ones and to possibly increase the survival rates of people who suffer from chronic kidney disease (CKD). Opterion Health was founded in 2012 by healthcare experts. The Company, based in Switzerland, is one of the few research-driven companies developing a novel PD solution. Opterion Health is privately held and financed by Angel Investors. The new Opterion dialysis solution is the first innovation … Type: | 1 | 0 | 1 | 11 |
 | sensawear AG Beyond Pressure We develop wearable, textile-integrated tissue oxygenation and pressure sensors using the principle of near-infrared spectroscopy. Special fiber optics seamlessly integrated thin, wearable, adhesive sensors give users real-time feedback of their tissue oxygen saturation and pressure against the skin. This will allow the user to be aware of low-oxygenation conditions induced by high-pressure points, indicating they should move or be moved. Our technology will help prevent painful and dangerous pressure injuries/pressure ulcers from forming by allowing targeted intervention with minimal repositioning. This means giving back control to people spending their day in a wheelchair, such as paraplegics, by allowing … Type: | 0 | 0 | 0 | 4 |
 | Shield Therapeutics plc Helping patients become people again Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead product Accrufer®/Feraccru® (ferric maltol). The Group has launched Accrufer® in the US and Feraccru® is commercialized in the UK and European Union by Norgine B.V., who also have the marketing rights in Australia and New Zealand. Shield also has an exclusive license agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of Accrufer® / Feraccru® in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. in the Republic of Korea, and with … Type: | 0 | 0 | 0 | 76 |
 | Eevia Health The organic health ingredient company from the north Eevia Health is the producer of 100% organic natural extracts from plants growing in the pristine wild Finnish forests of the Arctic Circle. All wild raw materials such as lingonberry, bilberry, chaga and pine bark are hand-picked and carefully processed into highest-quality, standardised extracts in Eevia’s own production facilities in Finland. These extremely potent ingredients are a perfect fit in dietary supplements, functional beverages and superfoods, to support healthier and happier lives. Short value chain controlled by Eevia together with organic certification gives assurance of the origin, authenticity and traceability. Eevia Health … Type: | 0 | 0 | 0 | 16 |
 | Synamics Therapeutics Pioneering Adaptive Medicine: AI-Powered Solutions to Overcome Drug Resistance in Cancer and Infectious Diseases At Synamics Therapeutics, our mission is crystal clear: we harness advanced computational and AI/ML techniques to profoundly impact patients' lives. As an end-to-end drug discovery company, we're dedicated to revolutionizing intractable cancer and infectious diseases through AI-powered adaptive drug design. Our interdisciplinary team uncovers drug resistance mechanisms, identifies unique therapeutic targets, and customizes treatments based on individual molecular profiles. We're driven by a deep commitment to redefine healthcare through next-generation precision medicine and AI-driven drug discovery. Beyond genomics, we employ a versatile approach to dissect proteins … Type: | 4 | 0 | 3 | 7 |
 | TOLREMO therapeutics Stopping non-genetic cancer drug resistance as it emerges TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies. Led by phenotypic insights, we discovered a pivotal mechanism that governs critical transcriptional resistance pathways. Our clinical compound TT125-802 is an orally available small molecule inhibitor designed to block these survival techniques to significantly improve the response rates and durability of established treatments. By stopping cancer drug resistance as it emerges, we aim to surmount a universal challenge for current and future targeted therapies for lasting patient benefit. Drug Discovery, Drug Development, Cancer Drug … Type: | 2 | 0 | 2 | 14 |
 | BariaTek BariaTek is a clinical stage company dedicated to treating obesity via a reversible non-invasive endoscopic approach. BariaTek Medical is a clinical stage company dedicated to addressing obesity via minimally invasive endoscopic approaches. Obesity is one of the most debilitating pandemics affecting humanity: More than 2 billion people are overweight of which 1 billion suffer from obesity. People suffering from obesity tend to lead shorter, less healthy, lives. Treating overweight-related conditions (diabetes, hypertension, sleep apnea and others) is projected to cost G-20 nations on average 8.7% of their health budgets over the next three decades which is estimated by the United … Type: | 1 | 0 | 1 | 15 |
 | NOVONIX NOVONIX is a battery materials and technology company providing revolutionary solutions to the EV and ESS markets. NOVONIX is a developer and supplier of high performance materials, and technologies for the global lithium-ion battery industry with operations in the USA and Canada. NOVONIX is comprised of 2 businesses: NOVONIX Battery Technology Solutions (BTS) based in Halifax and NOVONIX Anode Materials based in Chattanooga. NOVONIX Battery Technology Solutions (BTS), spun out of Dr. Jeff Dahn’s lab at Dalhousie University, provides the most accurate battery cell testing in the world. NOVONIX BTS’ equipment and cell testing services are used by leading battery … Type: | 2 | 0 | 2 | 158 |
 | Cleancard Combining synthetic biology and artificial intelligence to make cancer screening as easy as a pregnancy test. Cleancard is bringing lab-grade diagnostics into the comfort of your home. Our novel method enables robust diagnostics and biomarker tracking from the urine in just 30 minutes. Our rapid at-home screens can identify prostate, bladder and ovarian cancers. We are constantly expanding the number of conditions we can detect from a single sample using our platform technology. Type: | 0 | 0 | 0 | 4 |
 | Penrhos Bio A Joint Venture with Unilever PLC, creating a world free of harmful Biofilms though novel technology inspired by Nature. Were are a Joint Venture initiative with Unilever PLC formed in late 2019 with exclusive rights to the commercialise a new and novel technology based on furanone chemistry that inhibits Biofilms. Inspired by the biology of red seaweed, this single molecule platform offers a sustainable low-toxicity alternative to existing biocides. It has activity against bacteria by blocking quorum sensing and communication through multiple identified molecular targets in the bacteria, but is also effective against moulds and algae making this a unique … Type: | 0 | 0 | 0 | 8 |
 | TriptoBIO Access to plant diversity TriptoBIO is developing a platform for producing natural plant compounds that will support the health of our planet. Our goal is to create a future where everyone can benefit from the power of plants, without depleting natural resources. We are applying cutting-edge synthetic biology techniques to produce a class of plant compounds, called diterpenoids, via fermentation. This will enable novel applications of plant diterpenoids and revolutionize a range of industries - while avoiding intensive plant farming and petrochemicals. Our first product will liberate the world from rat poison, by supporting safe rat sex. Type: | 1 | 0 | 1 | 9 |
 | SOLID Therapeutics An early-stage oncology company aiming to treat solid tumors SOLID Therapeutics is an early-stage oncology company spun out of CBMR at the University of Copenhagen. We are developing novel cancer therapeutics with dual mode of action targeting both cancer cells and immune cells to treat solid tumors. Type: | 1 | 0 | 1 | 9 |
 | HHC medical Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies Type: | 1 | 0 | 1 | 21 |
 | FimmCyte First disease modifying treatment for Endometriosis. First disease modifying treatment for Endometriosis | 0 | 0 | 0 | 5 |
 | Dycotec Materials Dycotec Materials Ltd, based in the UK, is an advanced materials company developing and manufacturing electronic inks. Dycotec Materials Ltd, based in the UK, is an advanced materials company developing and manufacturing conductive, insulator and barrier layer inks and coatings for electronics and clean technology applications. In addition to our standard range of products, we work with our customers to tailor materials specifically to meet their requirements. Our materials are subjected to rigorous testing standards to ensure approval in applications for the military and industrial sectors. Working in conjunction with our materials development activities, our dedicated engineering team has expertise … Type: | 0 | 0 | 0 | 11 |
 | aiXscale Photonics GmbH Scaling up fiber-to-chip coupling Uniquely enabled by waferscale precision glass molding technology, aiXscale Photonics supplies proprietary ultra-high precision optical glass interposer solutions for reliable, low loss and cost effective assembly of transceiver optical subassemblies and co-packaged optics. We serve the needs of current and next generation high-volume Datacom and Telecom applications. Want to make your custom Photonic Integrated Circuit (PIC) a plug & play device? We provide scalable and low cost optical interfacing to a standard MPO connector. aiXscale Photonics was founded in 2017 by Jeremy Witzens and Florian Merget as a spin-off from the Institute of Integrated Photonics of … Type: | 0 | 0 | 0 | 4 |
 | MediSensonic [Automatic translation follows] We are a team of scientists and experts united by a common vision - we want to create diagnostics for the future. Our interdisciplinary research teams develop a number of extremely precise measurement devices for continuous imaging and monitoring of phenomena occurring in the body, in various areas of medicine - from a device for non-invasive diagnosis of the condition of the dental pulp, to an innovative system for monitoring glycemia. Our vision is medicine that, using innovative technological solutions, puts the patient's well-being first. This is what non-invasive diagnostics is. Type: | 7 | 0 | 7 | 17 |
 | OKYO Pharma OKYO focuses on novel GPCR based therapeutics for eye diseases of unmet need and non-opioid analgesics for chronic pain. OKYO Pharma focuses on: A novel class of membrane-anchored Chemerin receptor GPCR agonist that targets the inflammatory pathways to treat dry eye syndrome, uveitis and allergic conjunctivitis. An agonist for MAS-Related G Protein-Coupled Receptor (MRGPR), a non-opioid analgesic, for ocular and chronic pain management using novel topical and nasal formulations. Type: | 2 | 0 | 0 | 9 |
 | Mikrobiomik rethinking microbiome Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome. Our vision We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure. Our values Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic … Type: | 1 | 0 | 1 | 19 |
 | Bastion Therapeutics Creating a future where inflammatory disorders are curable Bastion Therapeutics is a preclinical stage biotechnology company with a mission to develop novel Treg therapies to address the unmet clinical need for inflammatory disorders. We leverage our proprietary GRITTM platform technology to enhance Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg therapies. Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders. Type: | 5 | 0 | 5 | 9 |
 | ThirtyFiveBio Applying proprietary understanding of GPR35 biology to develop novel small-molecule modulators. ThirtyFiveBio is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of GPR35. We are currently engaged in a fully enabled drug discovery program to identify novel small-molecule modulators of GPR35 Type: | 1 | 0 | 1 | 15 |
 | SuperLight Photonics Leading the industrial revolution in integrated wide-bandwidth laser sources SuperLight Photonics, a leading innovator in laser technology, specializes in the development of supercontinuum generation lasers, also known as wideband lasers or white lasers. Emerging from Twente University, the Netherlands, and based in Enschede, the company is driven by a vision to become a market leader. With a focus on applications such as spectrometry, OCT, surface inspection, crop management, and pollution detection, SuperLight Photonics is at the forefront of creating transformative photon-IC (PIC) based solutions. By harnessing the momentum within the photonics sector, SuperLight Photonics is contributing to a technologically advanced … | 1 | 0 | 1 | 12 |
 | BioLamina Cell-specific culture matrices for improved cell functionality BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a variety of applications, including the reliable expansion of pluripotent cell and differentiation and maintenance of specialized cell types. Our chemically defined and xeno-free laminin cell culture matrices allow you to imitate the natural cell-matrix interaction in vitro. Laminins are key components of the extracellular matrix. Through their interactions with specific receptors, laminins trigger the authentic cellular responses, pivotal for cell anchorage, survival, proliferation, migration, organization, … Type: | 0 | 0 | 0 | 96 |
 | Rejuveron Life Sciences AG Helping people live longer, healthier lives. Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team applies a deep understanding of the biology of aging, alongside technological advances in biopharmaceutical R&D, to progress a new generation of medicines that will help people to age better and live longer. Type: | 0 | 0 | 0 | 17 |
Startup